跳至主要内容
临床试验/IRCT20201229049877N1
IRCT20201229049877N1已完成3 期

Primary Evaluation of Anti hyperglycemic Effect of internal septum of Juglans regia in patients with diabetes mellitus type II: A Double blind Randomized Clinical Trial

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 70 years(—)
性别
All

入选标准

  • Obtain consent from patients
  • Age between 25 and 70 year old
  • HbA1C=7% and less than 9% and FPG = 130-250 mg / dl
  • Take metformin and/or other anti-diabetic agents (in maximum and constant dose for three months) or metformin alone (in maximum and constant dose for three months)
  • Constant diet and physical activity during the study (according to a questionnaire translated and validated into Persian)
  • The patient's anti-diabetic medication regimen remained constant during the study
  • No allergies to walnuts

排除标准

  • History of walnut allergy
  • Immune system defects
  • Pregnancy and lactation
  • Cardiovascular disease (coronary artery ischemia, EF <45%)
  • Take medications that change blood glucose levels (corticosteroids, tacrolimus, anti-AIDS drugs, antipsychotic drugs)
  • Uncontrolled thyroid disease
  • Acute infection
  • History of diabetic ketoacidosis
  • eGFR<60 ml/min
  • Acute hepatitis (increase in ALT and AST to more than 10 to 20 times normal)
  • Proliferative retinopathy
  • Severe weight loss (at least 10% over 6 months)
  • Consumption of any other medicine and herbal products, including walnuts

研究者

相似试验